US2023270631A1PendingUtilityA1
Topical glycopyrrolate formulations
Est. expiryOct 18, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61K 8/0208A61K 8/4913A61Q 15/00A61K 31/40A61K 47/10A61K 9/0014A61K 47/32A61P 17/00A61P 43/00A61P 7/00
83
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
Claims
exact text as granted — not AI-modified1 - 35 . (canceled)
36 . An individually packaged wipe for the treatment of hyperhidrosis comprising about 0.25 to about 6% w/w of a glycopyrrolate compound, wherein said wipe is contained within a pouch resistant to leakage.
37 . A method for alleviating hyperhidrosis in a mammal comprising the topical administration of the wipe of claim 1 to an area of the body such that the hyperhidrosis is substantially reduced.
38 . A method of preparing an individually packaged wipe for the treatment of hyperhidrosis comprising the steps of:
(a) contacting a wipe with a solution comprising glycopyrrolate compound at about 0.25 to about 6% w/w until wet; and (b) sealing the wipe of step (a) in a pouch resistant to leakage.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.